文献速递水电解质与酸碱

按预期治疗效果对低渗性低钠血症进行三维定量分类

Classifying Hypotonic Hyponatremia by Projected Treatment Effects - A Quantitative 3-Dimensional Framework.
PubMed 文献 · Kidney Int Rep · 2023-09-09

该研究基于Co-Med观察性研究的279例患者数据,将低渗性低钠血症按高净自由水摄入、尿液稀释受损和低非电解质溶质排泄三个维度同时定量评估,计算标准Δ钠反映各维度对血钠的预期影响。结果显示多数病例为多因素致病,77.5%患者存在2种或全部3种机制。

要点

  • 低渗性低钠血症应视为多因素致病,多数患者同时存在至少2种机制。
  • 尿液稀释受损是标准Δ钠最高的维度,占68.5%病例的主要贡献。
  • 三个维度可同时定量评估,有助于个体化分析低钠血症的病理生理机制。

核心结论

  • 低渗性低钠血症可通过三个维度进行定量定义,多数病例应视为多因素致病。

研究设计与样本

  • 基于既往观察性Co-Med研究的临床数据,对279例低渗性低钠血症患者进行三维定量分析。

主要发现

  • 在自由水摄入和尿渗透压目标为第5百分位、非电解质溶质排泄为第95百分位时,标准Δ钠中位数(IQR)分别为高净自由水摄入7.1(4.8-10.2)、尿液稀释受损11.8(7.0-18.6)、低非电解质溶质排泄2.6(1.6-4.2)mmol/l每24小时。
  • 标准Δ钠最高的维度为尿液稀释受损者占68.5%,高净自由水摄入占30.8%,低非电解质溶质排泄占0.7%。
  • 在标准Δ钠至少4 mmol/l每24小时的水平,高净自由水摄入的患病率为78.9%,尿液稀释受损为87.1%,低非电解质溶质排泄为26.5%。
  • 77.5%的患者存在2种或全部3种机制。
  • 按经典低钠血症分类和典型合并症分亚组,低钠血症也多为多因素致病。

临床怎么用

  • 临床评估低渗性低钠血症时,应同时考虑自由水摄入、尿液稀释能力和溶质排泄三个维度,避免仅关注尿液稀释受损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The diagnostic algorithms currently used for hypotonic hyponatremia focus primarily on impaired urinary dilution and often neglect the influence of free water intake and solute excretion. We hypothesized that, in each case of hypotonic hyponatremia different pathophysiological mechanisms play a role simultaneously. METHODS: Using clinical data of the previous observational Co-Med study, we defined each case of hypotonic hyponatremia concurrently in 3 dimensions as follows: (i) high net free water intake (HNFWI), (ii) impaired dilution of the urine (IDU), and (iii) low nonelectrolyte solute excretion (LNESE). For each dimension, a "standard delta sodium" (sdna) was calculated reflecting the expected difference to the serum sodium concentration, that would result from changing a dimension to a specific and equivalent target level. RESULTS: Results from 279 patients were used for this analysis. With target levels of free water intake and urine osmolality at the fifth percentile, and nonelectrolyte solute excretion at the 95th percentile, median (interquartile range) sdna values were 7.1 (4.8-10.2) for HNFWI, 11.8 (7.0-18.6) for IDU and 2.6 (1.6-4.2) mmol/l per 24 hours for LNESE. Sdna results in individual patients were highest with IDU in 68.5%, HNFWI in 30.8% and 0.7% with LNESE. At an sdna-level of at least 4mmol/l per 24 hours, the prevalence of HNFWI was 78.9%, IDU 87.1%, and LNESE 26.5%. 77.5% of patients had 2 or all 3 mechanisms present. Hyponatremia was mostly multifactorial in subgroups according to classic categories of hyponatremia and typical comorbidities as well. CONCLUSION: Hypotonic hyponatremia can be quantitatively defined by 3 dimensions. Most cases should be considered multifactorial.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Buchkremer F, Schuetz P, Mueller B, et al. Classifying Hypotonic Hyponatremia by Projected Treatment Effects - A Quantitative 3-Dimensional Framework. Kidney Int Rep. 2023. PMID: 38106585. doi:10.1016/j.ekir.2023.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。